Description: Two studies have found that a new drug, Noxafil, prevents fungal infections better than existing medications among high-risk patients and also seems to have fewer side effects. Invasive fungal infections are a leading cause of death among people undergoing chemotherapy for blood cancers, bone marrow transplants or organ transplants and who have low white blood cell counts as a result.